Full Coverage

Abraxis and ProMetic Enter License Agreements for up to $295 M US for Four Biopharmaceuticals

                   
pharmiweb.co.uk
04-Sep-2008
        
Story Timeline:  91 days

Abraxis Makes Initial $7 M US Equity Investment in ProMetic, with Future Additional Optional Equity Investments of Up to $25 M US LOS ANGELES & MONTREAL-- --Abraxis BioScience, Inc. (NASDAQ:ABII) and ProMetic Life Sciences Inc. (TSX:PLI) announced today that they have signed definitive agreements for the development and commercialization, on a world-wide basis (excluding China and Taiwan), of four... [read full story]                    

Add Comment
Latest article on this story:

Abraxis to partner with ProMetic on 4 drugs

 ibtimes.com 05-Sep-2008
First article on this story:

Abraxis and ProMetic Enter License Agreements for Up to $295 M US For Four Biopharmaceuticals

 pharmiweb.co.uk 04-Sep-2008
Selected publications with coverage of this story:
ibtimes.com pharmiweb.co.uk
RELATED
Found 1 documents:

Abraxis and ProMetic Enter License Agreements for Up to $295 M US For Four Biopharmaceuticals

pharmiweb.co.uk
04-Sep-2008
        

Abraxis Makes Initial $7 M US Equity Investment in ProMetic, with Future Additional Optional Equity Investments of Up to $25 M US LOS ANGELES, CALIFORNIA, USA and MONTREAL, QUEBEC, CANADA--(Marketwire - Sept. 4, 2008) -...